A hospital-based study: Risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy


Benbir G., Ozekmekci S., Apaydin H. , Delil S., Erginoz E.

CLINICAL NEUROLOGY AND NEUROSURGERY, cilt.108, ss.726-732, 2006 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 108 Konu: 8
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1016/j.clineuro.2006.02.002
  • Dergi Adı: CLINICAL NEUROLOGY AND NEUROSURGERY
  • Sayfa Sayıları: ss.726-732

Özet

Objectives: Although levodopa (LD) is the gold standard therapy for symptomatic treatment of Parkinson's disease (PD), the chronic use of LD leads to the development of motor complications in almost all patients.